Indication
Short Stature in Children Born Small for Gestational Age (SGA)
1 clinical trial
2 products
Clinical trial
A Dose-finding Trial Evaluating the Effect and Safety of Once-weekly Treatment of Somapacitan Compared to Daily Norditropin® in Children With Short Stature Born Small for Gestational Age With no Catch-up Growth by 2 Years of Age or OlderStatus: Active (not recruiting), Estimated PCD: 2021-05-05
Product
Norditropin®Product
Somapacitan